You are here

ARN-509

This Week in Biotech

Motley Fool

Sun, 06/23/13 - 11:11 am

pain management

prostage cancer

J&J to Buy Aragon Pharmaceuticals for Cancer Candidate

Bloomberg

Mon, 06/17/13 - 09:15 am

prostate cancer

Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation

Yahoo/Minyanville

Tue, 04/23/13 - 03:30 pm

prostate cancer